<DOC>
	<DOCNO>NCT01793662</DOCNO>
	<brief_summary>Patients severe atherosclerotic occlusive disease operate aortobifemoral bypass ( ABFB ) median laparotomy . Since 1993 , vary operation also perform laparoscopically . The laparoscopic ABFB operation claim minimally invasive compare open ABFB . The cohort study publish far show although long operation time laparoscopic procedure compare open surgery , patient shorter hospital stay , less perioperative bleeding , few systemic complication earlier reconvalescence . However , randomize control trial yet publish compare two procedure . In NLAST-study , multicenter randomize control trial , patient TASC type D atherosclerotic lesion shall randomize either totally laparoscopic aortobifemoral bypass operation ( LABFB ) open ABFB operation .</brief_summary>
	<brief_title>Norwegian Laparoscopic Aortic Surgery Trial</brief_title>
	<detailed_description>The primary end point study post-operative complication define systemic local complication , include vascular complication e.g. , graft infection , thrombosis etc . Secondary end point follow , - health relate quality life examine evaluate help pre post-operative survey perform help SF36v2 questionnaire EQ5D5L . - peri operative stress response ( operation ) measured/ analyse help stress hormone change - cost utility analysis - comparison 3D 2D laparoscopy , - etc .</detailed_description>
	<mesh_term>Leriche Syndrome</mesh_term>
	<criteria>Aortoiliac occlusive disease ( TASC Type D lesion ) Active cancer disease Acute critical limb ischemia Prior major abdominal surgery Heart failure ( Ejection fraction &lt; 40 %</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Aortobifemoral bypass</keyword>
	<keyword>Laparoscopic aortic surgery</keyword>
	<keyword>Aortoiliac occlusive disease</keyword>
	<keyword>TASC Type D Lesions</keyword>
	<keyword>Open aortic surgery</keyword>
</DOC>